Published Medical miRNA for PAH Treatment The 5HT1B receptor is a target for a miRNA in human pulmonary artery smooth muscle cell systems (PASMC). A miRNA mimic could be a novel and effective strategy to treat PAH. By University of Glasgow
Published Sciences MicroRNA MiRNA’s would, for the first time, provide the opportunity to inhibit atherosclerosis and restenosis while simultaneously stimulating therapeutic neovascularization. By Leiden University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
